Novozymes A/S (OTCMKTS:NVZMY – Get Free Report) was the target of a significant growth in short interest in March. As of March 15th, there was short interest totalling 1,700 shares, a growth of 1,600.0% from the February 28th total of 100 shares. Based on an average daily volume of 27,500 shares, the days-to-cover ratio is currently 0.1 days. Currently, 0.0% of the company’s stock are short sold.
Novozymes A/S Stock Performance
OTCMKTS NVZMY opened at $57.73 on Friday. Novozymes A/S has a one year low of $52.96 and a one year high of $72.50. The firm has a 50 day simple moving average of $57.89 and a 200-day simple moving average of $60.58. The firm has a market cap of $27.03 billion, a price-to-earnings ratio of 36.54, a PEG ratio of 3.87 and a beta of 0.91.
Novozymes A/S Increases Dividend
The business also recently disclosed a dividend, which will be paid on Wednesday, April 23rd. Stockholders of record on Monday, April 7th will be given a dividend of $0.3758 per share. The ex-dividend date is Monday, April 7th. This is a positive change from Novozymes A/S’s previous dividend of $0.17. Novozymes A/S’s dividend payout ratio is currently 94.94%.
Novozymes A/S Company Profile
Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.
Featured Stories
- Five stocks we like better than Novozymes A/S
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to SellĀ
- Consumer Discretionary Stocks Explained
- Top 3 Beverage Stocks Pouring Out Profits
- Industrial Products Stocks Investing
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.